Evidence map›Paper›PMID 33903945›Full record

ArticleAnalytical and bioanalytical chemistry2021

Mass spectrometric analysis of adducts of sulfur mustard analogues to human plasma proteins: approach towards chemical provenancing in biomedical samples.

Maria Hemme, Alex Fidder, Debora van der Riet-van Oeveren, Marcel J van der Schans, Daan Noort

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria HemmeChemistry Department, University of Hamburg, Martin-Luther-King-Platz 6, 20146, Hamburg, Germany.
Alex FidderDepartment of CBRN Protection, TNO Defence, Safety & Security, P.O. Box 45, 2280 AA, Rijswijk, The Netherlands.
Debora van der Riet-van OeverenDepartment of CBRN Protection, TNO Defence, Safety & Security, P.O. Box 45, 2280 AA, Rijswijk, The Netherlands.
Marcel J van der SchansDepartment of CBRN Protection, TNO Defence, Safety & Security, P.O. Box 45, 2280 AA, Rijswijk, The Netherlands.
Daan NoortDepartment of CBRN Protection, TNO Defence, Safety & Security, P.O. Box 45, 2280 AA, Rijswijk, The Netherlands. daan.noort@tno.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary aim of this study was to identify biomarkers of exposure to some so-called Schedule 1 sulfur mustard (HD) analogues, in order to facilitate and expedite their retrospective analysis in case of alleged use of such compounds. Since these HD analogues can be regarded as model compounds for possible impurities of HD formed during synthesis processes, the secondary aim was to explore to which extent these biomarkers can be used for chemical provenancing of HD in case biomedical samples are available. While the use of chemical attribution signatures (CAS) for neat chemicals or for environmental samples has been addressed quite frequently, the use of CAS for investigating impurities in biomedical samples has been addressed only scarcely. Human plasma was exposed to each of the five HD analogues. After pronase or proteinase K digestion of precipitated protein and sample work-up, the histidine (His) and tripeptide (CPF) adducts to proteins were analyzed, respectively. Adducts of the analogues could still be unambiguously identified next to the main HD adducts in processed plasma samples after exposure to HD mixed with each of the analogues, at a 1% level relative to HD. In conclusion, we have identified plasma protein adducts of a number of HD analogues, which can be used as biomarkers to assess an exposure to these Schedule 1 chemicals. We have shown that adducts of these analogues can still be analyzed after work-up of plasma samples which had been exposed to these analogues in a mixture with HD, supporting the hypothesis that biomedical sample analysis might be useful for chemical provenancing.

Indexed as

BiomarkersBlood ProteinsChemical Warfare AgentsHumansMass SpectrometryMustard GasBiomarkersBlood ProteinsChemical Warfare AgentsMustard GasAnaloguesChemical attribution signaturesChemical warfare agentLC-MS/MSProtein adductSulfur mustard

Identifiers

PMID33903945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.